Cesar Moran Selected Research

Cesar Moran Research Topics

Disease

28	Neoplasms (Cancer) 01/2023 - 08/2004
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2007
13	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2008
7	Adenocarcinoma of Lung 10/2022 - 08/2008
7	Adenocarcinoma 01/2018 - 07/2007
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 07/2007
3	Neoplasm Metastasis (Metastasis) 03/2010 - 07/2007
2	Thymoma (Thymic Carcinoma) 09/2023 - 06/2008
1	Inflammation (Inflammations) 07/2021
1	Adenoma (Adenomas) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Proteinuria 05/2017
1	Carcinoid Tumor (Carcinoid) 05/2017
1	Fatigue 05/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Nausea 05/2017
1	Neutropenia 05/2017
1	Malignant Mesothelioma 06/2014
1	Mesothelioma 06/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2012
1	Pericarditis 02/2011
1	Bronchiolitis 02/2011
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2011
1	Bronchiolitis Obliterans Syndrome 02/2011
1	Carcinoma in Situ 02/2010
1	Hyperplasia 02/2010
1	Brain Neoplasms (Brain Tumor) 05/2009
1	Lymphatic Metastasis 08/2008
1	Weight Loss (Weight Reduction) 07/2007
1	Large Cell Carcinoma 07/2007
1	Sarcoma (Soft Tissue Sarcoma) 12/2006
1	Paraganglioma (Paragangliomas) 01/2006
1	Small Cell Carcinoma 08/2004

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 07/2021 - 03/2010
5	Formaldehyde (Formol)FDA Link 01/2019 - 08/2008
5	Proteins (Proteins, Gene)FDA Link 04/2011 - 01/2008
4	ParaffinIBA 01/2019 - 09/2011
3	ErbB Receptors (EGF Receptor)IBA 05/2011 - 12/2006
2	AntibodiesIBA 09/2023 - 09/2009
2	B7-H1 AntigenIBA 07/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 07/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2010
2	Tyrosine Kinase InhibitorsIBA 03/2018 - 05/2011
2	LigandsIBA 01/2018 - 10/2017
2	VimentinIBA 05/2009 - 12/2006
1	AntigensIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 07/2021
1	Adenosine (Adenocard)FDA LinkGeneric 07/2021
1	EnzymesIBA 07/2021
1	nintedanibIBA 01/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	NucleotidesIBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018
1	Immune Checkpoint ProteinsIBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	IACS-010759IBA 01/2018
1	MucinsIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 05/2017
1	Interferon alpha-2 (Roferon-A)FDA Link 05/2017
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2017
1	Histones (Histone)IBA 02/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 06/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2012
1	Thyroid Nuclear Factor 1IBA 04/2011
1	Messenger RNA (mRNA)IBA 02/2010
1	Estrogen Receptor betaIBA 09/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2009
1	Estrogen Receptor alphaIBA 09/2009
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2009
1	integrin alphavbeta6IBA 05/2009
1	Cadherins (E-Cadherin)IBA 05/2009
1	ClusterinIBA 12/2006
1	Keratins (Keratin)IBA 12/2006
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2006
1	CollagenIBA 01/2006
1	ChromograninsIBA 01/2006
1	SynaptophysinIBA 01/2006
1	AsbestosIBA 09/2005

Therapy/Procedure

9	Therapeutics 01/2020 - 01/2008
4	Immunotherapy 10/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2020 - 08/2004
2	Radiotherapy 04/2018 - 06/2008
2	Chemoprevention 05/2009 - 08/2008
1	Lasers (Laser) 01/2021
1	Adjuvant Chemotherapy 01/2019
1	Neoadjuvant Therapy 01/2018
1	Cell Transplantation 02/2011
1	Stem Cell Transplantation 02/2011
1	Induction Chemotherapy 07/2007
1	Cystectomy 08/2004